Estrogen-induced cardiorenal protection: potential cellular, biochemical, and molecular mechanisms

被引:209
作者
Dubey, RK
Jackson, EK
机构
[1] Univ Zurich Hosp, Dept Obstet & Gynecol, Clin Endocrinol, CH-8051 Zurich, Switzerland
[2] Univ Pittsburgh, Med Ctr, Ctr Clin Pharmacol, Pittsburgh, PA 15213 USA
[3] Univ Pittsburgh, Med Ctr, Dept Med, Pittsburgh, PA 15213 USA
[4] Univ Pittsburgh, Med Ctr, Dept Pharmacol, Pittsburgh, PA 15213 USA
关键词
estradiol; metabolism; methoxyestradiol; hyperplasia; growth factors; antimitogenic; menopause; smooth muscle cells; mesangial cells; endothelial cells;
D O I
10.1152/ajprenal.2001.280.3.F365
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
A number of cellular and biochemical processes are involved in the pathophysiology of glomerular and vascular remodeling, leading to renal and vascular disorders, respectively. Although estradiol protects the renal and cardiovascular systems, the mechanisms involved remain unclear. In this review we provide a discussion of the cellular, biochemical, and molecular mechanisms by which estradiol may exert protective effects on the kidneys and vascular wall. In this regard, we consider the possible role of genomic vs. nongenomic mechanisms and estrogen receptor-dependent vs. estrogen receptor-independent mechanisms in mediating the protective effects of estradiol on the renal and cardiovascular systems.
引用
收藏
页码:F365 / F388
页数:24
相关论文
共 310 条
[1]   Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis [J].
Adams, MR ;
Register, TC ;
Golden, DL ;
Wagner, JD ;
Williams, JK .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (01) :217-221
[2]   INHIBITION OF CORONARY-ARTERY ATHEROSCLEROSIS BY 17-BETA ESTRADIOL IN OVARIECTOMIZED MONKEYS - LACK OF AN EFFECT OF ADDED PROGESTERONE [J].
ADAMS, MR ;
KAPLAN, JR ;
MANUCK, SB ;
KORITNIK, DR ;
PARKS, JS ;
WOLFE, MS ;
CLARKSON, TB .
ARTERIOSCLEROSIS, 1990, 10 (06) :1051-1057
[3]   ESTROGEN METABOLISM AND EXCRETION IN ORIENTAL AND CAUCASIAN WOMEN [J].
ADLERCREUTZ, H ;
GORBACH, SL ;
GOLDIN, BR ;
WOODS, MN ;
DWYER, JT ;
HAMALAINEN, E .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (14) :1076-1082
[4]   IN-VIVO REGULATION OF LOW-DENSITY-LIPOPROTEIN RECEPTORS BY ESTROGEN DIFFERS AT THE POSTTRANSCRIPTIONAL LEVEL IN RAT AND MOUSE [J].
AJIT, R ;
SRIVASTAVA, K ;
BAUMANN, D ;
SCHONFELD, G .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 216 (02) :527-538
[5]   Estrogen attenuates endothelin-1 production by bovine endothelial cells via estrogen receptor [J].
Akishita, M ;
Kozaki, K ;
Eto, M ;
Yoshizumi, M ;
Ishikawa, M ;
Toba, K ;
Orimo, H ;
Ouchi, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 251 (01) :17-21
[6]   Estrogen inhibits cuff-induced intimal thickening of rat femoral artery: Effects on migration and proliferation of vascular smooth muscle cells [J].
Akishita, M ;
Ouchi, Y ;
Miyoshi, H ;
Kozaki, K ;
Inoue, S ;
Ishikawa, M ;
Eto, M ;
Toba, K ;
Orimo, H .
ATHEROSCLEROSIS, 1997, 130 (1-2) :1-10
[7]   Basic fibroblast growth factor release by human coronary artery endothelial cells is enhanced by matrix proteins, 17β-estradiol, and a PKC signaling pathway [J].
Albuquerque, MLC ;
Akiyama, SK ;
Schnaper, HW .
EXPERIMENTAL CELL RESEARCH, 1998, 245 (01) :163-169
[8]  
Ali SH, 1999, MOL CELL ENDOCRINOL, V152, P1
[9]   17 beta-estradiol inhibits apoptosis of endothelial cells [J].
Alvarez, RJ ;
Gips, SJ ;
Moldovan, N ;
Wilhide, CC ;
Milliken, EE ;
Hoang, AT ;
Hruban, RH ;
Silverman, HS ;
Dang, CV ;
GoldschmidtClermont, PJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 237 (02) :372-381
[10]  
[Anonymous], NATURE